Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.

Detalhes bibliográficos
Main Authors:	Färnert, A, Lindberg, J, Gil, P, Swedberg, G, Berqvist, Y, Thapar, M, Lindegårdh, N, Berezcky, S, Björkman, A
Formato:	Journal article
Idioma:	English
Publicado em:	2003

Registos relacionados

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
Por: van Vugt, M, et al.
Publicado em: (2002)

Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
Por: McKeage, K, et al.
Publicado em: (2003)

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
Por: Mcgready, R, et al.
Publicado em: (2003)

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
Por: Thapar, M, et al.
Publicado em: (2002)

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Por: Lacy, MD, et al.
Publicado em: (2002)

Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
Por: Mcgready, R, et al.
Publicado em: (2003)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
Por: Maude, R, et al.
Publicado em: (2014)

Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil).
Por: Butcher, G, et al.
Publicado em: (2000)

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Por: Ling, J, et al.
Publicado em: (2002)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
Por: Staines, H, et al.
Publicado em: (2017)

The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
Por: Enosse, S, et al.
Publicado em: (2000)

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (malarone) when taken as chemoprophylaxis
Por: Mita, T, et al.
Publicado em: (2003)

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis
Por: Mita, T, et al.
Publicado em: (2003)

Absence of an interaction between artesunate and atovaquone--proguanil.
Por: van Vugt, M, et al.
Publicado em: (1999)

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
Por: Mcgready, R, et al.
Publicado em: (2005)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
Por: Chiodini, P, et al.
Publicado em: (1995)

Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
Por: Gupta, R, et al.
Publicado em: (2005)

Artemisinin resistance in Plasmodium falciparum malaria.
Por: Dondorp, A, et al.
Publicado em: (2009)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
Por: Chotivanich, K, et al.
Publicado em: (2012)

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Por: Krudsood, S, et al.
Publicado em: (2005)

Simultaneous quantitation of the highly lipophilic atovaquone and hydrophilic strong basic proguanil and its metabolites using a new mixed-mode SPE approach and steep-gradient LC.
Por: Lindegårdh, N, et al.
Publicado em: (2005)

Combating multidrug-resistant Plasmodium falciparum malaria.
Por: Thu, A, et al.
Publicado em: (2017)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
Por: Dondorp, A, et al.
Publicado em: (2009)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine in combination treatment of uncomplicated falciparum malaria in pediatric patients
Por: Hietala, S, et al.
Publicado em: (2009)

Spread of artemisinin resistance in plasmodium falciparum malaria
Por: Tripura, Rupam, et al.
Publicado em: (2015)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Por: Hietala, S, et al.
Publicado em: (2010)

Spread of artemisinin resistance in Plasmodium falciparum malaria.
Por: Ashley, E, et al.
Publicado em: (2014)

Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.
Por: Butcher, G, et al.
Publicado em: (2003)

Artemisinin Resistance in Plasmodium falciparum Malaria (vol 361, pg 455, 2009)
Por: Dondorp, A, et al.
Publicado em: (2009)

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.
Por: Ariey, F, et al.
Publicado em: (2014)

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Por: Ariey, F, et al.
Publicado em: (2014)

Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania.
Por: Färnert, A, et al.
Publicado em: (2012)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
Por: Rijken, M, et al.
Publicado em: (2007)

Intrahost modeling of artemisinin resistance in Plasmodium falciparum
Por: Saralamba, S, et al.
Publicado em: (2010)

Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
Por: Saralamba, S, et al.
Publicado em: (2011)

Anaemia of Plasmodium falciparum malaria.
Por: Phillips, R, et al.
Publicado em: (1992)

Management of Plasmodium falciparum malaria.
Por: Phillips, R
Publicado em: (1984)

Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia.
Por: Maude, R, et al.
Publicado em: (2014)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
Por: Karyana, M, et al.
Publicado em: (2008)

Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
Por: Maguire, J, et al.
Publicado em: (2006)